Harvard Bioscience(US:HBIO) Globenewswireยท2025-08-04 20:30Core Viewpoint - Harvard Bioscience, Inc. will announce its financial results for Q2 2025 on August 11, 2025, before market opening, followed by a conference call at 8:00 a.m. Eastern Time [1]. Company Overview - Harvard Bioscience, Inc. is a prominent developer, manufacturer, and seller of technologies, products, and services that facilitate advancements in life sciences, including research, drug discovery, bio-production, and preclinical testing for pharmaceutical development [3]. - The company's customer base includes prestigious academic institutions, government laboratories, and leading pharmaceutical, biotechnology, and contract research organizations globally [3]. - Harvard Bioscience operates in the United States, Europe, and China, utilizing both direct and distribution channels to reach customers worldwide [3].